Effect of Bifidobacterium Breve PRL2020 (an Amoxicillin-clavulanate-resistant Strain) on Gastrointestinal Symptoms and Gut Microbiota Composition in Children Treated With Amoxicillin or Amoxicillin/Clavulanate

NCT05840588 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

121

Enrollment

OTHER

Sponsor class

Conditions

Bacterial Infections

Interventions

DRUG: Antibiotic Treatment
DIETARY_SUPPLEMENT: Probiotic Bifidobacterium breve PRL2020 (Brevicillin®) treatment

Sponsor

Liaquat University of Medical & Health Sciences

Collaborators

[object Object]